Global Database of Emerging Companies
A powerful research and due diligence tool for investors, entrepreneurs, and business development executives
The OneMedPlace Global Database is the best first stop to learning about the companies and technologies shaping the future of health and medicine. To gain access to full access to this database register.
Searched: Management-Consulting 1 - 30 of 52 results Next >
Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 2 of 5.
Mark V. Pauly, PhD, Bendheim professor of healthcare management, business public policy, insurance and risk management, and economics at the Wharton School of the University of Pennsylvania discusses the utility and use of comparative effectiveness research for the health insurance industry at the 2010 InHealth Health Technology Summit, held April 7, in Washington, DC. Part 1 of 5.
Management Interview: Epion Health
Management Interview: Aptiv Solutions
Inside Endeavour Vision: Interviews with the Management
RAPID Pharmaceuticals focuses on developing pharmaceutical compounds modulating the activity of cell surface receptors. Their technology allows the synthesis of short receptor active peptides derived from larger human or viral proteins, which they modify and stabilize into potent bioactive therapeutic compounds. These therapeutic compounds of endogenous peptide hormones or proteins may then be used as bodywide mediators that regulate communication within and among the nervous, immune and glandular systems.
CeQur is an insulin delivery device company, developing and commercializing a small, discrete, and uniquely simple insulin delivery device for people with type 2 diabetes. The Company was established in January 2008 as a spin-out from Danfoss A/S, a large, global, Danish industrial products group that had developed the core technology, product concept and early prototypes. CeQur is a Swiss-registered private company with operations in Denmark and Marlborough, MA, USA.
Management Interview: Neil Warma, CEO of Opexa Therapeutics
Management Interview: Evian Gordon of Brain Resource
Management Interview: Mitchell Seyedin, CEO of ISTO Technologies
Management Interview: Aftab Jamil, of BDO USA
Management Interview: Micro Interventional Devices
Management Interview: Greater Zurich Area AG
OneMedTV interviews Dr. Phillip Chan, CEO of CytoSorbents at the OneMedForum San Francisco 2012.
Management Interview: Gregory J. Kuehn, of Metabiomics
Management Interview: Pat Donnelly, CEO of Aptiv Solutions
EpiCept presents at OneMedForum San Francisco 2011
Gemma GarcÃa Zato, Co-Founder and Deputy General Manager of 2B Blackbio, is interviewed at the 2012 OneMedForum San Francisco.
Frank K. Bedu-Addo, Ph.D., President and CEO of Pds Biotechnology, discusses their therapeutic vaccine technology, how it works, and how PDS plans to apply that technology moving forward.
P. Kay Wagoner, President, CEO, and Director of Icagen, gives a presentation on her company at the 2010 OneMedForum in San Francisco.
WaferGen Biosystems, Inc., provides genomics analysis solutions from research to clinic for the life science and pharmaceutical industries. Its high-throughput, nano-scale genomics solutions are designed to revolutionize disease research, improve drug development efficiency, enable personalized medicine and impact health care economics. Its experienced management team drives a compelling business model that brings revenue from sales of its high margin instruments and recurring-revenue of consumables (chips).
Bryan W. Hughes, Director at P&m Corporate Finance, discusses his company, with a focus on their advisory services for middle market companies.